CDC: “Interim Medical Factors To Consider for Usage of mRNA COVID-19 Vaccines Presently Licensed in the United States.”
Blanka Kaplan, MD, adult and pediatric allergic reaction and immunology expert, Northwell Health, Great Neck, NY.
Aaron E. Glatt, MD, chief, contagious illness and health center epidemiologist, Mount Sinai South Nassau; teacher of medication, Icahn School of Medication at Mount Sinai, Oceanside, NY.
Tara Vijayan, MD, contagious illness expert and assistant teacher of medication, UCLA David Geffen School of Medication.
Martin Floreani, president and CEO, Dentovations, Boston.
The Journal of the American Medical Association: “Allergies Consisting Of Anaphylaxis After Invoice of the First Dosage of Pfizer-BioNTech COVID-19 Vaccine.”
Prostate: “Result of 25- hydroxyvitamin D status on serological action to influenza vaccine in prostate cancer clients.”
Infections: “Standard Serum Vitamin A and D Levels Determine Advantage of Oral Vitamin A&D Supplements to Humoral Immune Reactions Following Pediatric Influenza Vaccination.”